Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Murat Tuzcu is active.

Publication


Featured researches published by E. Murat Tuzcu.


Circulation | 2013

Impact of Aortic Valve Replacement on Outcome of Symptomatic Patients With Severe Aortic Stenosis With Low Gradient and Preserved Left Ventricular Ejection Fraction

Alper Ozkan; Rory Hachamovitch; Samir Kapadia; E. Murat Tuzcu; Thomas H. Marwick

Background— The optimal management of low-gradient “severe” aortic stenosis (mean gradient <40 mm Hg, indexed aortic valve area ⩽0.6 cm2/m2) with preserved left ventricular ejection fraction remains controversial because gradients may be similar after aortic valve replacement (AVR). We compared outcomes of low-gradient severe aortic stenosis with AVR or medical therapy. Methods and Results— Comprehensive echocardiographic measurements including hemodynamic calculations were completed in 260 prospectively identified patients with symptomatic low-gradient severe aortic stenosis. Patients were followed up for mortality over 28±24 months. AVR was performed in 123 patients (47%). Compared with AVR patients, medically treated patients had a higher prevalence of diabetes mellitus (25% versus 41%, P=0.009), lower stroke volume index (36.4±8.4 versus 34.4±8.7 mL/m2, P=0.02), higher pulmonary artery pressure (38±11 versus 48±21 mm Hg, P=0.001), and higher creatinine level (1.1±0.4 versus 1.22±0.5 mg/dL, P=0.02). These and other clinically relevant variables were entered into a propensity model that reflected likelihood of referral to AVR. This score and other variables were entered into a Cox model to explore the independent effect of AVR on outcome. During follow-up, 105 patients died (40%): 32 (30%) in the AVR group and 73 (70%) in the medical treatment group. AVR (hazard ratio, 0.54; 95% confidence interval, 0.32–0.94; P<0.001) was independently associated with outcome and remained a strong predictor of survival after adjustment for propensity score. Medical therapy was associated with 2-fold greater all-cause mortality than AVR. The protective effect of AVR was similar in 125 patients with normal flow (stroke volume index >35 mL/m2; P=0.22). Conclusions— AVR is associated with better survival than medical therapy in patients with symptomatic low-gradient severe AS and preserved left ventricular ejection fraction.


Archive | 2011

Hypertrophic Cardiomyopathy Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for

Bruce W. Lytle; Samir R. Kapadia; Shikhar Agarwal; E. Murat Tuzcu; Milind Y. Desai; Nicholas G. Smedira


Archive | 2011

Burden Measured by Intravascular Ultrasound Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease

Steven E. Nissen; Samir R. Kapadia; Stanley L. Hazen; Chuan-Chuan Wun; Michele Norton; Stephen J. Nicholls; E. Murat Tuzcu; Tim Crowe; Ilke Sipahi; Paul Schoenhagen


Archive | 2011

percutaneous coronary revascularization in diabetics The importance of proteinuria as a determinant of mortality following

Russell E. Raymond; Eric J. Topol; Steven P. Marso; Stephen G. Ellis; E. Murat Tuzcu; Patrick L. Whitlow; Irving Franco


Archive | 2010

on Progression of Coronary Atherosclerosis Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels

Craig Balog; Tim Crowe; Steven E. Nissen; Ilke Sipahi; E. Murat Tuzcu; Paul Schoenhagen; Katherine E. Wolski


Archive | 2009

Contemporary Reviews in Interventional Cardiology Interventional Cardiology Perspective of Functional Tricuspid Regurgitation

Shikhar Agarwal; E. Murat Tuzcu; E. Rene Rodriguez; Carmela D. Tan; L. Leonordo Rodriguez; Samir R. Kapadia


Archive | 2008

Septal ablation for HCM

Amy L. Seidel; Samir R. Kapadia; Harry M. Lever; E. Murat Tuzcu


Essential Interventional Cardiology (Second Edition) | 2008

Chapter 35 – Septal ablation for HCM

Amy L. Seidel; Samir R. Kapadia; Harry M. Lever; E. Murat Tuzcu


Archive | 2004

Effet d'un traitement hypolipémiant intensif comparé à un traitement modéré sur la progression de l'athérosclérose coronaire Essai randomisé et comparatif

Steven E. Nissen; E. Murat Tuzcu; Paul Schoenhagen; B. Greg Brown; Peter Ganz; Robert A. Vogel; Tim Crowe; Christopher J. Cooper; Bruce Brodie; Cindy L. Grines; Anthony N. DeMaria


Archive | 2004

Effet de certains antihypertenseurs sur les événements cardio-vasculaires chez des patients coronariens à pression artérielle normale

Steven E. Nissen; E. Murat Tuzcu; Peter Libby; Paul D. Thompson; Magdi Ghali; Dahlia Garza; Lance Berman; Harry H. Shi; Eric J. Topol

Collaboration


Dive into the E. Murat Tuzcu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ilke Sipahi

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alper Ozkan

Menzies Research Institute

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge